Skip to search formSkip to main contentSkip to account menu

Aricept

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
Alzheimer's disease (AD) is a neurodegenerative disorder that affects over 45 million people worldwide. Patients with severe AD… 
Review
2008
Review
2008
BACKGROUND Delirium is now the preferred term to describe acute confusional states. It is experienced by 10 to 30% of all… 
Review
2004
Review
2004
  • D. Geldmacher
  • Expert review of neurotherapeutics
  • 2004
  • Corpus ID: 24517595
Alzheimer´s disease is common, incurable and disabling. It is expected to grow dramatically in prevalence over the next 50 years… 
Highly Cited
2003
Highly Cited
2003
Primary objective : To investigate the effectiveness of donepezil hydrochloride (Aricept®) in treating persistent memory deficits… 
Review
2003
Review
2003
SIR: We read with interest, the review by Griffin et. al. on the use of cholinergic agents in the treatment of persons who… 
Highly Cited
2000
Highly Cited
2000
The extracellular deposition of amyloid beta‐peptide (Aβ) in the form of cerebrovascular amyloid and extracellular plaques is one… 
2000
2000
The extracellular deposition of amyloid beta-peptide (Abeta) in the form of cerebrovascular amyloid and extracellular plaques is… 
Highly Cited
1999
Highly Cited
1999
Donepezil hydrochloride (Aricept) is a drug for the treatment of Alzheimer's disease. The absorption, distribution, metabolism…